Treatment of Toxic Epidermal Necrolysis (TEN) with low dose intravenous immunoglobulin in child

Journal of the College of Physicians and Surgeons Pakistan

Volumn 20, Issue 3, 2010, Pages 205-207

  Habib, Aamir ^a   Pasha, Waseem ^a,b   Raza, Naeem ^a,b  

^a Peshawar Cantonment   (Pakistan)

^b PAF Hospital Faisal   (Pakistan)

Author keywords

Intravenous immunoglobulin; Paediatrics; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

ANALGESIC AGENT; ANTIPYRETIC AGENT; ATROPINE; CEFIPIME; CEPHALOSPORIN; CIPROFLOXACIN; CLOXACILLIN; FUSIDIC ACID; IMMUNOGLOBULIN; INFUSION FLUID; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANAMNESIS; ARTICLE; CASE REPORT; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; CONSERVATIVE TREATMENT; EYE DISEASE; HUMAN; LOW DRUG DOSE; MALE; MUCOSAL DISEASE; ORAL MUCOSAL DISEASE; PHYSICAL EXAMINATION; PRESCHOOL CHILD; RASH; SECONDARY INFECTION; SKIN DISEASE; STEVENS JOHNSON SYNDROME; TOTAL PARENTERAL NUTRITION; TOXIC EPIDERMAL NECROLYSIS;

CHILD, PRESCHOOL; EPIDERMAL NECROLYSIS, TOXIC; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MALE;

EID: 77950501263     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Fritsch PO, Rulz-Maldonado R. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, editors. Fitzpatrick's dermatology in general medicine, 6th ed. New York: McGraw-Hill, 2003.p. 543-557
2. Teo L, Tay YK, Liu TT, Kwok C. Stevens-Johnson syndrome and toxic epidermal necrolysis: efficacy of intravenous immunoglobulin and a review of treatment options. Singapore Med J 2009; 50:29-33.
3. Pereira FA, Mudgil AV, Rosamarin DM. Toxic epidermal necrolysis. J Am Acad Dermatol 2007; 56:181-200.
4. Viard I, Wehrli P, Bullani R. Schneider P, Holler N, Salomon D, et al. Inhibition of TEN by blockade of CD 95 with human IVIG. Science 1998; 282:490-493
5. Mangla K, Rastogi S, Goyal P, Solanki RB, Rawal RC. Efficacy of low dose intravenous immunoglobulins in children with toxic epidermal necrolysis: an open uncontrolled study. Indian J Dermatol Venereol Leprol 2005; 71:398-400.
6. Fasano MB. Risks and benefits of Intravenous immunoglobulin treatment in children. Curr Opin Pediatr 1995; 7:688-694
7. Prins C, Kerdel FA, Padilla RS, Hunziker T, Chimenti S, Viard I, et al. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol 2003; 139:26-32.
8. Mittmann N, Chan B, Knowles S, Cosentino L, Shear N. Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome. Am J Clin Dermatol 2006; 7:359-368
9. Metry DW, Jung P, Levy ML. Use of intravenous immunoglobulin in children with Stevens-Johnson syndrome and toxic epidermal necrolysis: seven cases and review of the literature. Pediatrics 2003; 112:1430-1436
10. Tristani-Firouzi P, Petersen MJ, Saffle JR, Morris SE, Zone JJ. Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children. J Am Acad Dermatol 2002; 47:548-552